Literature DB >> 18813852

Urokinase-type plasminogen activator receptor is associated with macrophages and plaque rupture in symptomatic carotid atherosclerosis.

Per-Arne Svensson1, Fredrik J Olson, Daniel A Hägg, Mikael Ryndel, Olov Wiklund, Lars Karlström, Johannes Hulthe, Lena M S Carlsson, Björn Fagerberg.   

Abstract

There is a strong correlation between macrophage infiltration and plaque instability in recently symptomatic carotid atherosclerotic plaques, and it is hypothesised that mechanisms related to macrophages may be involved in plaque vulnerability and rupture. We previously found high expression of urokinase-type plasminogen activator receptor (UPAR) in human macrophages. The aim of this study was to investigate whether UPAR co-localises with macrophages in symptomatic carotid plaques, and whether UPAR expression is associated with plaque rupture. Real-time RT-PCR assays showed that UPAR expression levels were high in monocyte-derived macrophages and in carotid endarterectomies compared with a tissue panel. Serial transverse sections were prepared from carotid endarterectomies from 12 symptomatic patients, and analyzed with immunohistochemical staining for UPAR and for CD68-positive macrophages, and with histopathological assessment. UPAR co-localised with CD68-positive macrophages, with a high correlation (r=0.90, p<0.001) between immunostained areas in 12 carotid endarterectomies from symptomatic patients. High degrees of UPAR and CD68 staining were found in sections around the bifurcation level where rupture was most common, while low degrees of staining were found in sections of the common carotid artery end of the endarterectomy (p<0.05). Higher degrees of UPAR staining were observed in ruptured plaque sections compared with non-ruptured sections. In conclusion, UPAR was highly expressed in monocyte-derived macrophages and in symptomatic carotid plaques, UPAR co-localised with macrophages in carotid symptomatic plaques and UPAR was predominantly found in ruptured plaque segments. These findings support the hypothesis that UPAR is related to plaque rupture in symptomatic atherosclerotic lesions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18813852

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  16 in total

1.  High molecular weight kininogen binds phosphatidylserine and opsonizes urokinase plasminogen activator receptor-mediated efferocytosis.

Authors:  Aizhen Yang; Jihong Dai; Zhanli Xie; Robert W Colman; Qingyu Wu; Raymond B Birge; Yi Wu
Journal:  J Immunol       Date:  2014-03-31       Impact factor: 5.422

2.  Overexpression of urokinase by plaque macrophages causes histological features of plaque rupture and increases vascular matrix metalloproteinase activity in aged apolipoprotein e-null mice.

Authors:  Jie Hong Hu; Liang Du; Talyn Chu; Goro Otsuka; Nagadhara Dronadula; Mia Jaffe; Sean E Gill; William C Parks; David A Dichek
Journal:  Circulation       Date:  2010-03-29       Impact factor: 29.690

3.  Biomarkers of kidney injury and klotho in patients with atherosclerotic renovascular disease.

Authors:  Moo Yong Park; Sandra M Herrmann; Ahmed Saad; Alfonso Eirin; Hui Tang; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Clin J Am Soc Nephrol       Date:  2014-12-26       Impact factor: 8.237

4.  Blockade of Ets-1 attenuates epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cells.

Authors:  Velidi H Rao; Vikrant Rai; Samantha Stoupa; Devendra K Agrawal
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-07       Impact factor: 4.733

Review 5.  Perspectives for Monocyte/Macrophage-Based Diagnostics of Chronic Inflammation.

Authors:  Julia Kzhyshkowska; Alexandru Gudima; Kondaiah Moganti; Alexei Gratchev; Alexander Orekhov
Journal:  Transfus Med Hemother       Date:  2016-03-15       Impact factor: 3.747

Review 6.  Vasa vasorum in atherosclerosis and clinical significance.

Authors:  Junyan Xu; Xiaotong Lu; Guo-Ping Shi
Journal:  Int J Mol Sci       Date:  2015-05-20       Impact factor: 5.923

7.  First-in-human uPAR PET: Imaging of Cancer Aggressiveness.

Authors:  Morten Persson; Dorthe Skovgaard; Malene Brandt-Larsen; Camilla Christensen; Jacob Madsen; Carsten H Nielsen; Tine Thurison; Thomas Levin Klausen; Søren Holm; Annika Loft; Anne Kiil Berthelsen; Michael Ploug; Helle Pappot; Klaus Brasso; Niels Kroman; Liselotte Højgaard; Andreas Kjaer
Journal:  Theranostics       Date:  2015-09-13       Impact factor: 11.556

8.  Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma.

Authors:  Joo Ern Ang; Akos Pal; Yasmin J Asad; Alan T Henley; Melanie Valenti; Gary Box; Alexis de Haven Brandon; Victoria L Revell; Debra J Skene; Miro Venturi; Ruediger Rueger; Valerie Meresse; Suzanne A Eccles; Johann S de Bono; Stanley B Kaye; Paul Workman; Udai Banerji; Florence I Raynaud
Journal:  Mol Cancer Ther       Date:  2017-06-21       Impact factor: 6.261

9.  Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation.

Authors:  Joo Ern Ang; Rupinder Pandher; Joo Chew Ang; Yasmin J Asad; Alan T Henley; Melanie Valenti; Gary Box; Alexis de Haven Brandon; Richard D Baird; Lori Friedman; Mika Derynck; Bart Vanhaesebroeck; Suzanne A Eccles; Stan B Kaye; Paul Workman; Johann S de Bono; Florence I Raynaud
Journal:  Mol Cancer Ther       Date:  2016-04-05       Impact factor: 6.261

10.  Comprehensive analysis of dysregulated genes associated with atherosclerotic plaque destabilization.

Authors:  Cheng Qian; Yuling Jing; Meng Xia; Qiang Ye
Journal:  Exp Biol Med (Maywood)       Date:  2021-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.